Cytarabine Dose of 36 g/m<sup>2</sup> Compared With 12 g/m<sup>2</sup> Within First Consolidation in Acute Myeloid Leukemia: Results of Patients Enrolled Onto the Prospective Randomized AML96 Study
Markus Schaich(Rems-Murr-Klinikum), Gerhard Ehninger(University Hospital Carl Gustav Carus), Christian Thiede(University Hospital Carl Gustav Carus), Michael Krämer(University Hospital Carl Gustav Carus), Reingard Stuhlmann(Asklepios Klinik St. Georg), J. Tischler(Asklepios Klinik St. Georg), Silke Soucek(Klinik und Poliklinik für Psychotherapie und Psychosomatik), Uta Oelschlaegel(University Hospital Carl Gustav Carus), Christoph Röllig(University Hospital Carl Gustav Carus), Martin Bornhäuser(Technische Universität Dresden), H. Bodenstein(Pius Hospital Oldenburg), Walter E. Aulitzky(Robert Bosch Hospital), Anthony D. Ho(Heidelberg University), Martin Kaufmann(Robert Bosch Hospital), Hannes Wandt(Nuremberg Hospital), Brigitte Mohr(Klinik und Poliklinik für Psychotherapie und Psychosomatik), Kerstin Schäfer‐Eckart(Nuremberg Hospital), Norbert Schmitz(University Hospital Münster), Alwin Krämer(Heidelberg University), Johannes Schetelig(University Hospital Carl Gustav Carus)
Cited by 102
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k